A thioacetamide-induced hepatic encephalopathy model in C57BL/6 mice: A behavioral and neurochemical study;Modelo de encefalopatia hepática induzida por tioacetamida em camundongos C57BL/6: Estudo comportamental e neuroquímico

Arquivos de Neuro-Psiquiatria

Volumn 68, Issue 4, 2010, Pages 597-602

  de Miranda, Aline Silva ^a   Rodrigues, David Henrique ^a   Vieira, Luciene Bruno ^a   Lima, Cristiano Xavier ^a   Rachid, Milene Alvarenga ^a   Vidigal, Paula Vieira Teixeira ^a   Gomez, Marcus Vinicius ^a   dos Reis, Helton José ^a   Guatimosim, Cristina ^a   Teixeira, Antônio Lúcio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Behavioral changes; Glutamate; Hepatic encephalopathy; SHIRPA; Thioacetamide

Indexed keywords

GLUTAMIC ACID; NEUROTRANSMITTER; THIOACETAMIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CHEMICAL ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; FLUOROMETRY; HEPATIC ENCEPHALOPATHY; HISTOPATHOLOGY; LOCOMOTION; MOUSE; NEUROCHEMISTRY; NEUROPSYCHIATRY; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOGENESIS;

EID: 77957296799     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/s0004-282x2010000400022     Document Type: Article

References (29)

1. th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-721.
2. Raghavan M, Marik PE. Therapy of intracranial hypertension in patients with fulminant hepatic failure. Neurocrit Care 2006;4:179-189.
3. Rose C. Increased extracellular brain glutamate in acute liverfailure: decreased uptake or increased release? Metab Brain Dis 2002;17:251-261.
4. Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 2002;17:221-227.
5. Shawcross D, Jalan R. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell Mol Life Sci 2005;62:2295-2304.
6. Palomero-Gallagher N, Bidmon HJ, Cremer M, et al. Neurotransmitter receptor imbalances in motor cortex and basal ganglia in hepatic encephalopathy. Cell Physiol Biochem 2009;24:291-306.
7. Bélanger M, Côté J, Butterworth RF. Neurobiological characterization of an azoxymethane mouse model of acute liver failure. Neurochem Int 2006;48:434-440.
8. Avraham Y, Israeli E, Gabbay E, et al. Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. Neurobiol Dis 2006;21:237-245.
9. Rahman TM, Hodgson HJ. Animal models of acute hepatic failure. Int J Exp. Pathol 2000;81:145-157.
10. Wang CH, Jawan B, Lee TH, et al. Single injection of naked plasmid encoding alpha-melanocyte-stimulating hormone protects against thioacetamide-induced acute liver failure in mice. Biochem Biophys Res Commun 2004;322: 153-161.
11. Reddy PV, Murthy ChR, Reddanna P. Fulminant hepatic failure induced oxidative stress in nonsynaptic mitochondria of cerebral cortex in rats. Neurosci Lett 2004;368:15-20.
12. Chu CJ, Chen CT, Wang SS, et al. Hepatic encephalopathy in rats with thioacetamide induced fulminant hepatic failure: role of endotoxin and tumor necrosis factor-α. Chin Med J 2001;64:321-330.
13. Dagon Y, Avraham Y, Ilan Y, Mechoulam R, Berry EM. Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activated protein kinase. FASEB J 2007;21:2431-2441.
14. Bémeur C, Qu H, Desjardins P, Butterworth RF. IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure. Neurochem Int 2010;56:213-215.
15. Méndez M, Méndez-López M, López L, Aller MA, Arias J, Arias JL. Associative learning deficit in two experimental models of hepatic encephalopathy. Behav Brain Res 2009;198:346-351.
16. Sarhan S, Knödgen B, Grauffel C, Seiler N. Effects of inhibition of ornithine aminotransferase on thioacetamide-induced hepatogenic encephalopathy. Neurochem Res 1993;18:539-549.
17. Rogers DC, Fisher EM, Brown SD, Peters J, Hunter AJ, Martin JE. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 1997;8:711-713.
18. Lackner P, Beer R, Heussler V, et al. Behavioural and histopathological alterations in mice with cerebral malaria. Neuropathol Appl Neurobiol 2006;32:177-188.
19. Romano-Silva MA, Ribeiro-Santos R, Ribeiro AM, et al. Rat cortical synaptosomes have more than one mechanism for calcium entry linked to rapid glutamate release: studies using Phoneutria nigriventer toxin PhTX2 and potassium depolarization. Biochem J 1993;296:313-319.
20. Dunkley PR, Heath JW, Harrison SM, Jarvie PE, Glenfield PJ, Rostas JA. A rapid Percoll gradient procedure for isolation of synaptosomes directly from S1 fraction: homogeneity and morphology of subcellular fractions. Brain Res 1988;441:59-71.
21. Nicholls DG, Sihra TS, Sanchez-Prieto J. Calcium dependent and independent release of glutamate from synaptosomes monitored by continuous fluorometry. J Neurochem 1987;49:50-57.
22. Prado MAM, Guatimosim C, Gomez MV, Diniz CR, Cordeiro MN, Romano-Silva MA. A novel tool for the investigation of glutamate release from rat cerebrocortical synaptosomes: the toxin Tx3-3 from the venom of the spider Phoneutria nigriventer. Biochem J 1996;314:145-150.
23. 2+-ATPase: comparison of the enzymes' response to in vitro treatment with ammonia. Metab Brain Dis 2008; 23:255-264.
24. Fernández-Martínez A, Callejas NA, Casado M, Boscá L, Martín-Sanz P. Thioacetamide-induced liver regeneration involves the expression of cyclooxygenase 2 and nitric oxide synthase 2 in hepatocytes. J Hepatol 2004;40:963-970.
25. Okuyama H, Nakamura H, Shimahara Y, Araya S, Kawada N, Yamaoka Y, Yodoi J. Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice. Hepatology 2003;37:1015-1025.
26. Moroni F, Lombardi G, Moneti G, Cortesini C. The release and neosynthesis of glutamic acid are increased in experimental models of hepatic encephalopathy. J Neurochem 1983;40:850-854.
27. McArdle P, Penning DH, Dexter F, Reynolds JD. Flumazenil does not affect the increase in rat hippocampal extracellular glutamate concentration produced during thioacetamide-induced hepatic encephalopathy. Metab Brain Dis 1996;11:329-342.
28. Albrecht J, Hilgier W, Zielinska M, Januszewski S, Hesselink M, Quack G. Extra cellular concentrations of taurine, glutamate, and aspartate in the cerebral cortex of rats at the asymptomatic stage of thioacetamide-induced hepatic failure-modulation by ketamine anesthesia. Neurochem Res 2000;25:1497-1502.
29. 2+ release from thapsigargin-sensitive intracellular stores. Pflugers Arch 2000; 439:370-377.